
    
      Devices allowed in the study include any Medtronic single, dual, or triple chamber
      defibrillator that has received appropriate license or regulatory approval and is
      commercially available by Medtronic in the geography in which the implant will take place.
      Any market-released, commercially available lead(s) can be used in the study.
    
  